Jyingyang
2021-06-24
China lagging behind us
China stocks subdued as consumer gains counter losses in drugmakers
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
3
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":128506940,"tweetId":"128506940","gmtCreate":1624521982880,"gmtModify":1631884666037,"author":{"id":3557042150703199,"idStr":"3557042150703199","authorId":3557042150703199,"authorIdStr":"3557042150703199","name":"Jyingyang","avatar":"https://static.tigerbbs.com/8a8ba7eec847ba16499cee54495a9a24","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>China lagging behind us</p></body></html>","htmlText":"<html><head></head><body><p>China lagging behind us</p></body></html>","text":"China lagging behind us","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/128506940","repostId":2145010262,"repostType":4,"repost":{"id":"2145010262","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624520776,"share":"https://www.laohu8.com/m/news/2145010262?lang=&edition=full","pubTime":"2021-06-24 15:46","market":"sh","language":"en","title":"China stocks subdued as consumer gains counter losses in drugmakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2145010262","media":"Reuters","summary":"SHANGHAI, June 24 (Reuters) - China shares ended slightly higher on Thursday, as gains in consumer a","content":"<p>SHANGHAI, June 24 (Reuters) - China shares ended slightly higher on Thursday, as gains in consumer and new energy companies countered losses in healthcare companies, which were hit by worries of a slump in drug prices.</p>\n<p>** The blue-chip CSI300 index gained 0.2% at 5,155.97, while the Shanghai Composite Index was unchanged at 3,566.65.</p>\n<p>** The CSI300 healthcare index led declines, with a 1.7% fall, after price plunges were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>* The average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Drugmaker Hengrui , Asymchem Laboratories Tianjin Co Ltd and Bloomage Biotechnology Corp Ltd fell between 4.4% and 5.5%.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** Helping the market, the CSI300 consumer staples index and the CSI new energy index rose 0.9% and 0.8%, respectively.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon closed down 7.2% after the ban.</p>\n<p>** The pricing department of China's National Development and Reform Commission (NDRC) and the country's market regulator have sent teams to various Chinese provinces and cities to investigate bulk commodity prices and supplies.</p>\n<p>** The A-share resource industries index slipped 0.3% after the news.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks subdued as consumer gains counter losses in drugmakers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks subdued as consumer gains counter losses in drugmakers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-24 15:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHANGHAI, June 24 (Reuters) - China shares ended slightly higher on Thursday, as gains in consumer and new energy companies countered losses in healthcare companies, which were hit by worries of a slump in drug prices.</p>\n<p>** The blue-chip CSI300 index gained 0.2% at 5,155.97, while the Shanghai Composite Index was unchanged at 3,566.65.</p>\n<p>** The CSI300 healthcare index led declines, with a 1.7% fall, after price plunges were shown in the results of the fifth national government-backed drug bulk-buy program.</p>\n<p>* The average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.</p>\n<p>** Drugmaker Hengrui , Asymchem Laboratories Tianjin Co Ltd and Bloomage Biotechnology Corp Ltd fell between 4.4% and 5.5%.</p>\n<p>** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.</p>\n<p>** Helping the market, the CSI300 consumer staples index and the CSI new energy index rose 0.9% and 0.8%, respectively.</p>\n<p>** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.</p>\n<p>** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.</p>\n<p>** Hoshine Silicon closed down 7.2% after the ban.</p>\n<p>** The pricing department of China's National Development and Reform Commission (NDRC) and the country's market regulator have sent teams to various Chinese provinces and cities to investigate bulk commodity prices and supplies.</p>\n<p>** The A-share resource industries index slipped 0.3% after the news.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145010262","content_text":"SHANGHAI, June 24 (Reuters) - China shares ended slightly higher on Thursday, as gains in consumer and new energy companies countered losses in healthcare companies, which were hit by worries of a slump in drug prices.\n** The blue-chip CSI300 index gained 0.2% at 5,155.97, while the Shanghai Composite Index was unchanged at 3,566.65.\n** The CSI300 healthcare index led declines, with a 1.7% fall, after price plunges were shown in the results of the fifth national government-backed drug bulk-buy program.\n* The average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.\n** Drugmaker Hengrui , Asymchem Laboratories Tianjin Co Ltd and Bloomage Biotechnology Corp Ltd fell between 4.4% and 5.5%.\n** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.\n** Helping the market, the CSI300 consumer staples index and the CSI new energy index rose 0.9% and 0.8%, respectively.\n** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.\n** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.\n** Hoshine Silicon closed down 7.2% after the ban.\n** The pricing department of China's National Development and Reform Commission (NDRC) and the country's market regulator have sent teams to various Chinese provinces and cities to investigate bulk commodity prices and supplies.\n** The A-share resource industries index slipped 0.3% after the news.","news_type":1},"isVote":1,"tweetType":1,"viewCount":213,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["CAAS"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":20,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/128506940"}
精彩评论